Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 99mTc-GSA, Asialoscinti, アシアロシンチ |
Target- |
Mechanism SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date JP (03 Jul 1992), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | JP | 03 Jul 1992 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Diseases | Phase 1 | CN | 09 Jun 2021 | |
Liver Diseases | Phase 1 | CN | 09 Jun 2021 | |
Contrast agents | Phase 1 | CN | 24 Mar 2021 | |
Contrast agents | Phase 1 | CN | 24 Mar 2021 |
Not Applicable | 49 | (Planar scintigraphy) | oewizxwdsk(laqqeoykqk) = jokaagjpfj inmtgqalmu (flpclngeni, 7.0) | Positive | 18 Sep 2018 | ||
Not Applicable | - | - | (Normal group) | edyszjtjyr(kzbxsrwsmo) = znokxggric rmjbicjgrx (aitpaqghxf, 5.1) | - | 24 May 2016 | |
(Mild liver dysfunction group) | edyszjtjyr(kzbxsrwsmo) = fxqswvzbqo rmjbicjgrx (aitpaqghxf, 4.4) |